Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.

Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, Hakim J, Kumarasamy N, Campbell TB; ACTG PEARLS/A5175 Team..

J Infect Dis. 2017 Mar 15;215(6):907-910. doi: 10.1093/infdis/jix029.

PMID:
28453835
2.

Cervical Cancer Risk and Impact of Pap-based Screening in HIV-positive Women on Antiretroviral Therapy in Johannesburg, South Africa.

Rohner E, Sengayi M, Goeieman B, Michelow P, Firnhaber C, Maskew M, Bohlius J.

Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30749. [Epub ahead of print]

PMID:
28440019
3.

Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis.

Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E.

J Antimicrob Chemother. 2017 Apr 16. doi: 10.1093/jac/dkx107. [Epub ahead of print]

PMID:
28419314
4.

A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.

Smith JS, Sanusi B, Swarts A, Faesen M, Levin S, Goeieman B, Ramotshela S, Rakhombe N, Williamson AL, Michelow P, Omar T, Hudgens MG, Firnhaber C.

Am J Obstet Gynecol. 2017 Mar 31. pii: S0002-9378(17)30460-X. doi: 10.1016/j.ajog.2017.03.022. [Epub ahead of print]

PMID:
28366730
5.

Prevalence Of Anal Hpv And Anal Dysplasia In Hiv-Infected Women From Johannesburg, South Africa.

Goeieman BJ, Firnhaber CS, Jong E, Michelow P, Swarts A, Williamson AL, Allan B, Smith JS, Kegorilwe P, Wilkin TJ.

J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001300. [Epub ahead of print]

PMID:
28141783
6.

Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting.

Rayne S, Lince-Deroche N, Hendrickson C, Shearer K, Moyo F, Michelow P, Rubin G, Benn C, Firnhaber C.

BMC Health Serv Res. 2017 Jan 21;17(1):63. doi: 10.1186/s12913-016-1959-4.

7.

Awareness, perceived risk and practices related to cervical cancer and Pap smear screening: A cross-sectional study among HIV-positive women attending an urban HIV clinic in Johannesburg, South Africa.

Mokhele I, Evans D, Schnippel K, Swarts A, Smith JS, Firnhaber C.

S Afr Med J. 2016 Dec 1;106(12):1247-1253. doi: 10.7196/SAMJ.2016.v106.i12.11224.

PMID:
27917772
8.

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.

Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E.

BMC Infect Dis. 2016 Oct 21;16(1):593.

9.

High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.

Papasavvas E, Surrey LF, Glencross DK, Azzoni L, Joseph J, Omar T, Feldman MD, Williamson AL, Siminya M, Swarts A, Yin X, Liu Q, Firnhaber C, Montaner LJ.

Oncoimmunology. 2016 Jan 19;5(5):e1128612. doi: 10.1080/2162402X.2015.1128612. eCollection 2016 May.

10.

Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.

Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D.

Trop Med Int Health. 2016 Sep;21(9):1131-7. doi: 10.1111/tmi.12741. Epub 2016 Jul 7.

PMID:
27383454
11.

HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.

Michelow P, Firnhaber C.

Cancer. 2016 Oct;124(10):695-698. doi: 10.1002/cncy.21738. Epub 2016 May 16. No abstract available.

PMID:
27182785
12.

A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis.

Schnippel K, Ndjeka N, Conradie F, Berhanu R, Claasen Z, Banoo S, Firnhaber C.

S Afr Med J. 2016 Mar 17;106(4):30-1. doi: 10.7196/SAMJ.2016.v106i4.10205.

PMID:
27032841
13.

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).

Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL.

J Antimicrob Chemother. 2016 Jun;71(6):1609-18. doi: 10.1093/jac/dkw005. Epub 2016 Feb 17.

PMID:
26892777
14.

Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.

Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D; AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams..

Clin Infect Dis. 2016 May 1;62(9):1081-8. doi: 10.1093/cid/ciw035. Epub 2016 Feb 2.

15.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J; 5271 study team., Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A; AIDS Clinical Trials Group..

J Neurovirol. 2016 Aug;22(4):472-8. doi: 10.1007/s13365-015-0415-2. Epub 2016 Jan 5.

PMID:
26733457
16.

Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.

Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson AL, Allan B, Schnippel K, Smith JS.

PLoS One. 2016 Jan 5;11(1):e0144905. doi: 10.1371/journal.pone.0144905. eCollection 2016.

17.

Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.

Lince-Deroche N, Phiri J, Michelow P, Smith JS, Firnhaber C.

PLoS One. 2015 Nov 16;10(11):e0141969. doi: 10.1371/journal.pone.0141969. eCollection 2015.

18.

Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis.

Schnippel K, Michelow P, Chibwesha CJ, Makura C, Lince-Deroche N, Goeieman B, Mulongo M, Jordaan S, Firnhaber C.

BMC Health Serv Res. 2015 Nov 6;15:499. doi: 10.1186/s12913-015-1163-y.

19.

Anal dysplasia in HIV-infected women: a commentary on the field.

Godfrey C, Firnhaber CS, D'Souza G, Heard I.

Int J STD AIDS. 2017 May;28(6):543-549. doi: 10.1177/0956462415615764. Epub 2015 Nov 4. Review.

PMID:
26538554
20.

Persistent Tachypnea of Infancy. Usual and Aberrant.

Rauch D, Wetzke M, Reu S, Wesselak W, Schams A, Hengst M, Kammer B, Ley-Zaporozhan J, Kappler M, Proesmans M, Lange J, Escribano A, Kerem E, Ahrens F, Brasch F, Schwerk N, Griese M; PTI (Persistent Tachypnea of Infancy) Study Group of the Kids Lung Register..

Am J Respir Crit Care Med. 2016 Feb 15;193(4):438-47. doi: 10.1164/rccm.201508-1655OC.

PMID:
26474448

Supplemental Content

Loading ...
Support Center